» Articles » PMID: 22654557

Hashimoto's Thyroiditis: From Genes to the Disease

Overview
Journal Curr Genomics
Date 2012 Jun 2
PMID 22654557
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

Hashimoto's thyroiditis (HT) is the most prevalent autoimmune thyroid disorder. Intrathyroidal lymphocytic infiltration is followed by a gradual destruction of the thyroid gland which may lead to subclinical or overt hypothyroidism. Biochemical markers of the disease are thyroid peroxidase and/or thyroglobulin autoantibodies in the serum which are present with a higher prevalence in females than in males and increase with age. Although exact mechanisms of aetiology and pathogenesis of the disorder are not completely understood, a strong genetic susceptibility to the disease has been confirmed predominantly by family and twin studies. Several genes were shown to be associated with the disease occurrence, progression, and severity. Genes for human leukocyte antigen, cytotoxic T lymphocyte antigen-4, protein tyrosine phosphatase nonreceptor-type 22, thyroglobulin, vitamin D receptor, and cytokines are considered to be of utmost importance. Amongst endogenous factors for the disease development, the attention is focused predominantly on female sex, pregnancy with postpartum period and fetal microchimerism. Environmental factors influencing HT development are iodine intake, drugs, infections and different chemicals. Disturbed self-tolerance accompanied by the increased antigen presentation is a prerequisite for the HT occurrence, whereas proper interaction of thyroid cells, antigen presenting cells, and T cells are necessary for the initiation of thyroid autoimmunity. Secreted cytokines lead predominantly to T-helper type 1 (Th1) response as well as to Th 17 response which has only recently been implicated. Final outcome of HT is thyroid destruction which is mostly a consequence of the apoptotic processes combined with T-cell mediated cytotoxicity.

Citing Articles

Validation of DNA methylation and transcriptional characteristics in CCL5 and CXCL8 genes in autoimmune thyroiditis with varying iodine levels.

Chen Y, Liu J, Ren B, Zhou Z, He Y, Li F Sci Rep. 2025; 15(1):6006.

PMID: 39972165 PMC: 11840062. DOI: 10.1038/s41598-025-90499-x.


The prevalence of autoimmune thyroiditis is not increased in women with polycystic ovary syndrome after adjustment for family predisposition.

Vryonidou A, Mizamtsidi M, Palioura E, Kalogeris N, Vassilatou E, Ioannidis D Endocrine. 2025; .

PMID: 39883390 DOI: 10.1007/s12020-025-04181-3.


Evaluating the Role of CBC-Derived Indices in Children with Hashimoto's Thyroiditis.

Munteanu A, Juganaru I, Nicoara D, Mang N, Vasilescu R, Brad G Diagnostics (Basel). 2025; 14(24.

PMID: 39767195 PMC: 11675751. DOI: 10.3390/diagnostics14242834.


Evaluating the Influence of Hashimoto's Thyroiditis on Clinico-Pathological Characteristics and Prognostic Outcomes of Middle Eastern Differentiated Thyroid Carcinoma.

Parvathareddy S, Siraj A, Siraj N, Ahmed S, Al-Sobhi S, Al-Dayel F Int J Endocrinol. 2024; 2024:9929782.

PMID: 39309476 PMC: 11416175. DOI: 10.1155/2024/9929782.


The Impact of Environmental Factors on the Development of Autoimmune Thyroiditis-Review.

Cyna W, Wojciechowska A, Szybiak-Skora W, Lacka K Biomedicines. 2024; 12(8).

PMID: 39200253 PMC: 11351723. DOI: 10.3390/biomedicines12081788.


References
1.
Nagata S, Golstein P . The Fas death factor. Science. 1995; 267(5203):1449-56. DOI: 10.1126/science.7533326. View

2.
Knudsen N, Jorgensen T, Rasmussen S, Christiansen E, Perrild H . The prevalence of thyroid dysfunction in a population with borderline iodine deficiency. Clin Endocrinol (Oxf). 1999; 51(3):361-7. DOI: 10.1046/j.1365-2265.1999.00816.x. View

3.
Lin W, Wan L, Tsai C, Chen R, Lee C, Tsai F . Vitamin D receptor gene polymorphisms are associated with risk of Hashimoto's thyroiditis in Chinese patients in Taiwan. J Clin Lab Anal. 2006; 20(3):109-12. PMC: 6807492. DOI: 10.1002/jcla.20110. View

4.
McCombe P, Greer J, Mackay I . Sexual dimorphism in autoimmune disease. Curr Mol Med. 2009; 9(9):1058-79. DOI: 10.2174/156652409789839116. View

5.
Shevach E . From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity. 2006; 25(2):195-201. DOI: 10.1016/j.immuni.2006.08.003. View